Global Allergic Rhinitis Drugs Market Size, Share, Growth and Analysis Report 2016 - 2020 : Hexa Reports

Hexa Reports
Market Research Reports and Insightful Company Profiles

Global Allergic Rhinitis Drugs Market Share,
Trends, Size, Analysis and Forecasts 2016-2020

Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE)
type antibodies on the surface of mast cells. This interaction causes mast cells to release and
synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include
rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic
conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using
medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative
forms of treatment are also employed in certain cases.
Technavio's analysts forecast the global allergic rhinitis market to grow at a CAGR of 0.95% during
the period 2016-2020.
Browse Detail Report With TOC @
Covered in this report
The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs
market for the period 2016-2020. To calculate the market size, it considers revenue generated from
the sales of prescription and off-label drugs used to treat allergic rhinitis.
The market is divided into the following segments based on geography:
Technavio's report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers the market landscape
and its growth prospects over the coming years. The report also includes a discussion of the key
vendors operating in this market.

Hexa Reports
Market Research Reports and Insightful Company Profiles
Key vendors
Meda Pharmaceuticals
Other prominent vendros